+1 347 708 0418
The global RNAi for Therapeutic market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to all countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.
This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.
This report provides detailed historical analysis of global market for RNAi for Therapeutic from 2014-2019, and provides extensive market forecasts from 2020-2029 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the RNAi for Therapeutic market.
Leading players of RNAi for Therapeutic including:
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
Market split by Type, can be divided into:
siRNA
miRNA
shRNA
Market split by Application, can be divided into:
Cancer
Cardiovascular
HBV
Other
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 RNAi for Therapeutic Market Overview
1.1 RNAi for Therapeutic Definition
1.2 Global RNAi for Therapeutic Market Size Status and Outlook (2014-2029)
1.3 Global RNAi for Therapeutic Market Size Comparison by Region (2014-2029)
1.4 Global RNAi for Therapeutic Market Size Comparison by Type (2014-2029)
1.5 Global RNAi for Therapeutic Market Size Comparison by Application (2014-2029)
1.6 Global RNAi for Therapeutic Market Size Comparison by Sales Channel (2014-2029)
1.7 RNAi for Therapeutic Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 RNAi for Therapeutic Market Segment Analysis by Player
2.1 Global RNAi for Therapeutic Sales and Market Share by Player (2017-2019)
2.2 Global RNAi for Therapeutic Revenue and Market Share by Player (2017-2019)
2.3 Global RNAi for Therapeutic Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 RNAi for Therapeutic Market Segment Analysis by Type
3.1 Global RNAi for Therapeutic Market by Type
3.1.1 siRNA
3.1.2 miRNA
3.1.3 shRNA
3.2 Global RNAi for Therapeutic Sales and Market Share by Type (2014-2019)
3.3 Global RNAi for Therapeutic Revenue and Market Share by Type (2014-2019)
3.4 Global RNAi for Therapeutic Average Price by Type (2014-2019)
3.5 Leading Players of RNAi for Therapeutic by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 RNAi for Therapeutic Market Segment Analysis by Application
4.1 Global RNAi for Therapeutic Market by Application
4.1.1 Cancer
4.1.2 Cardiovascular
4.1.3 HBV
4.1.4 Other
4.2 Global RNAi for Therapeutic Sales and Market Share by Application (2014-2019)
4.3 Leading Consumers of RNAi for Therapeutic by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 RNAi for Therapeutic Market Segment Analysis by Sales Channel
5.1 Global RNAi for Therapeutic Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global RNAi for Therapeutic Sales and Market Share by Sales Channel (2014-2019)
5.3 Leading Distributors/Dealers of RNAi for Therapeutic by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 RNAi for Therapeutic Market Segment Analysis by Region
6.1 Global RNAi for Therapeutic Market Size and CAGR by Region (2014-2029)
6.2 Global RNAi for Therapeutic Sales and Market Share by Region (2014-2019)
6.3 Global RNAi for Therapeutic Revenue and Market Share by Region (2014-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America RNAi for Therapeutic Market Share by Type
6.4.3 North America RNAi for Therapeutic Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe RNAi for Therapeutic Market Share by Type
6.5.3 Europe RNAi for Therapeutic Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific RNAi for Therapeutic Market Share by Type
6.6.3 Asia-Pacific RNAi for Therapeutic Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America RNAi for Therapeutic Market Share by Type
6.7.3 South America RNAi for Therapeutic Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa RNAi for Therapeutic Market Share by Type
6.8.3 Middle East & Africa RNAi for Therapeutic Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading RNAi for Therapeutic Players
7.1 Alnylam Pharmaceuticals
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Alnylam Pharmaceuticals
7.2 Arbutus Biopharma (Tekmira)
7.3 Arrowhead
7.4 Dicerna Pharmaceuticals
7.5 Mirna Therapeutics
7.6 Quark Pharmaceuticals
7.7 RXi Pharmaceuticals
7.8 Silence Therapeutics
7.9 Benitec Biopharma
7.10 miRagen Therapeutics
7.11 Sylentis
7.12 Gradalis
7.13 Sirnaomics
7.14 Silenseed
Chapter 8 Upstream and Downstream Analysis of RNAi for Therapeutic
8.1 Industrial Chain of RNAi for Therapeutic
8.2 Upstream of RNAi for Therapeutic
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of RNAi for Therapeutic
8.3.1 Leading Distributors/Dealers of RNAi for Therapeutic
8.3.2 Leading Consumers of RNAi for Therapeutic
Chapter 9 Development Trend of RNAi for Therapeutic (2020-2029)
9.1 Global RNAi for Therapeutic Market Size (Sales and Revenue) Forecast (2020-2029)
9.2 Global RNAi for Therapeutic Market Size and CAGR Forecast by Region (2020-2029)
9.3 Global RNAi for Therapeutic Market Size and CAGR Forecast by Type (2020-2029)
9.4 Global RNAi for Therapeutic Market Size and CAGR Forecast by Application (2020-2029)
9.5 Global RNAi for Therapeutic Market Size and CAGR Forecast by Sales Channel (2020-2029)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure RNAi for Therapeutic Example
Figure Global RNAi for Therapeutic Revenue (Million $) Status and Outlook (2014-2029)
Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Region (2014-2029)
Figure Global RNAi for Therapeutic Sales Comparison by Type (2014-2029)
Figure Global RNAi for Therapeutic Sales Comparison by Application (2014-2029)
Figure Global RNAi for Therapeutic Sales Comparison by Sales Channel (2014-2029)
Table Global RNAi for Therapeutic Sales by Player (2017-2019)
Table Global RNAi for Therapeutic Sales Market Share by Player (2017-2019)
Figure Global RNAi for Therapeutic Sales Market Share by Player in 2019
Table Global RNAi for Therapeutic Revenue (Million $) by Player (2017-2019)
Table Global RNAi for Therapeutic Revenue Market Share by Player (2017-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Player in 2019
Table Global RNAi for Therapeutic Average Price by Player (2017-2019)
Figure Global RNAi for Therapeutic Average Price by Player in 2019
Figure Global RNAi for Therapeutic Players Competition Situation Top 5 Players Revenue Market Share in 2017
Figure Global RNAi for Therapeutic Players Competition Trends Top 5 Players Revenue Market Share in 2019
Figure Example of siRNA
Figure Global siRNA Sales and Growth Rate (2014-2019)
Figure Example of miRNA
Figure Global miRNA Sales and Growth Rate (2014-2019)
Figure Example of shRNA
Figure Global shRNA Sales and Growth Rate (2014-2019)
Table Global RNAi for Therapeutic Sales by Type (2014-2019)
Table Global RNAi for Therapeutic Sales Market Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Sales Market Share by Type in 2019
Table Global RNAi for Therapeutic Revenue (Million $) by Type (2014-2019)
Table Global RNAi for Therapeutic Revenue Market Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Type in 2019
Table Global RNAi for Therapeutic Average Price by Type (2014-2019)
Figure Global RNAi for Therapeutic Average Price by Type in 2019
Table Leading Players of RNAi for Therapeutic by Type in 2019
Figure Example of Cancer
Figure Global RNAi for Therapeutic for Cancer Sales and Growth Rate (2014-2019)
Figure Example of Cardiovascular
Figure Global RNAi for Therapeutic for Cardiovascular Sales and Growth Rate (2014-2019)
Figure Example of HBV
Figure Global RNAi for Therapeutic for HBV Sales and Growth Rate (2014-2019)
Figure Example of Other
Figure Global RNAi for Therapeutic for Other Sales and Growth Rate (2014-2019)
Table Global RNAi for Therapeutic Sales by Application (2014-2019)
Table Global RNAi for Therapeutic Sales Market Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Sales Market Share by Application in 2019
Table Leading Consumers of RNAi for Therapeutic by Application in 2019
Figure Example of Direct Channel
Figure Global RNAi for Therapeutic for Direct Channel Sales and Growth Rate (2014-2019)
Figure Example of Distribution Channel
Figure Global RNAi for Therapeutic for Distribution Channel Sales and Growth Rate (2014-2019)
Table Global RNAi for Therapeutic Sales by Sales Channel (2014-2019)
Table Global RNAi for Therapeutic Sales Market Share by Sales Channel (2014-2019)
Figure Global RNAi for Therapeutic Sales Market Share by Sales Channel in 2019
Table Leading Distributors/Dealers of RNAi for Therapeutic by Sales Channel in 2019
Table Global RNAi for Therapeutic Market Size and CAGR by Region (2014-2029)
Table Global RNAi for Therapeutic Sales by Region (2014-2019)
Table Global RNAi for Therapeutic Sales Market Share by Region (2014-2019)
Figure Global RNAi for Therapeutic Sales Market Share by Region in 2019
Table Global RNAi for Therapeutic Revenue (Million $) by Region (2014-2019)
Table Global RNAi for Therapeutic Revenue Market Share by Region (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Region in 2019
Table North America RNAi for Therapeutic Sales by Country (2014-2019)
Figure North America RNAi for Therapeutic Sales Market Share by Country (2014-2019)
Table North America RNAi for Therapeutic Revenue by Country (2014-2019)
Figure North America RNAi for Therapeutic Revenue Market Share by Country (2014-2019)
Figure North America RNAi for Therapeutic Sales Market Share by Type in 2019
Figure North America RNAi for Therapeutic Sales Market Share by Application in 2019
Figure United States RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure United States RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Canada RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Canada RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Mexico RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Mexico RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Table Europe RNAi for Therapeutic Sales by Country (2014-2019)
Figure Europe RNAi for Therapeutic Sales Market Share by Country (2014-2019)
Table Europe RNAi for Therapeutic Revenue by Country (2014-2019)
Figure Europe RNAi for Therapeutic Revenue Market Share by Country (2014-2019)
Figure Europe RNAi for Therapeutic Sales Market Share by Type in 2019
Figure Europe RNAi for Therapeutic Sales Market Share by Application in 2019
Figure Germany RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Germany RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure UK RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure UK RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure France RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure France RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Italy RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Italy RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Russia RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Russia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Spain RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Spain RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Table Asia-Pacific RNAi for Therapeutic Sales by Country (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Country (2014-2019)
Table Asia-Pacific RNAi for Therapeutic Revenue by Country (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Country (2014-2019)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Type in 2019
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Application in 2019
Figure China RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure China RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Japan RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Japan RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Korea RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Korea RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure India RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure India RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Southeast Asia RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Australia RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Australia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Table South America RNAi for Therapeutic Sales by Country (2014-2019)
Figure South America RNAi for Therapeutic Sales Market Share by Country (2014-2019)
Table South America RNAi for Therapeutic Revenue by Country (2014-2019)
Figure South America RNAi for Therapeutic Revenue Market Share by Country (2014-2019)
Figure South America RNAi for Therapeutic Sales Market Share by Type in 2019
Figure South America RNAi for Therapeutic Sales Market Share by Application in 2019
Figure Brazil RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Brazil RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Argentina RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Argentina RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Colombia RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Colombia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Table Middle East & Africa RNAi for Therapeutic Sales by Country (2014-2019)
Figure Middle East & Africa RNAi for Therapeutic Sales Market Share by Country (2014-2019)
Table Middle East & Africa RNAi for Therapeutic Revenue by Country (2014-2019)
Figure Middle East & Africa RNAi for Therapeutic Revenue Market Share by Country (2014-2019)
Figure Middle East & Africa RNAi for Therapeutic Sales Market Share by Type in 2019
Figure Middle East & Africa RNAi for Therapeutic Sales Market Share by Application in 2019
Figure UAE RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure UAE RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure Saudi Arabia RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure Saudi Arabia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Figure South Africa RNAi for Therapeutic Sales and Growth Rate (2014-2019)
Figure South Africa RNAi for Therapeutic Revenue (Million $) and Growth Rate (2014-2019)
Table Company Snapshot of Alnylam Pharmaceuticals
Table RNAi for Therapeutic Introduction of Alnylam Pharmaceuticals
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share of Alnylam Pharmaceuticals (2017-2019)
Table Industrial Chain of RNAi for Therapeutic
Table Manufacturing Cost Structure of RNAi for Therapeutic
Table General Manufacturing Process of RNAi for Therapeutic
Table Leading Distributors/Dealers of RNAi for Therapeutic
Table Leading Consumers of RNAi for Therapeutic
Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast (2020-2029)
Figure Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2020-2029)
Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Region (2020-2029)
Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Type (2020-2029)
Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Application (2020-2029)
Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Sales Channel (2020-2029)
Buy
